Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sipponen

Showing results (321-330 of 459) with videos related to

Pageof 46
Sort By:
Medicine|January 9, 2020
Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel diseaseSaara Huoponen, Anja Eberl, Pirjo Räsänen, et al.
Journal of Clinical Microbiology|June 10, 1998
Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritisA Kokkola, H Rautelin, P Puolakkainen, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1991
Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjectsK Villako, M Kekki, H I Maaroos, et al.
Scandinavian Journal of Gastroenterology|January 1, 1976
Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosisM P Salaspuro, O I Laitinen, J Lehtola, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 16, 2020
Well-Defined Lignin Model Films from Colloidal Lignin ParticlesMuhammad Farooq, Tao Zou, Juan José Valle-Delgado, et al.
Digestive Diseases and Sciences|February 13, 2025
Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel DiseaseJaakko Rautakorpi, Sara Kolehmainen, Eliisa Löyttyniemi, et al.
Perfusion|October 9, 2008
Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assistT T Niemi, S I Kukkonen, P T Hämmäinen, et al.
Endoscopy|May 1, 1990
Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long-term follow-up examinations of a random sampleK Villako, H Maards, R Tammur, et al.
European Journal of Gastroenterology & Hepatology|July 8, 2024
Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel diseaseSara Kolehmainen, Jaakko Rautakorpi, Eliisa Löyttyniemi, et al.
Inflammatory Bowel Diseases|September 23, 2010
Endoscopic monitoring of infliximab therapy in Crohn's diseaseClas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen, et al.
Pageof 46

Showing results (321-330 of 459) with videos related to

Sort By:
Pageof 46
Medicine|January 9, 2020
Health-related quality of life and costs of switching originator infliximab to biosimilar one in treatment of inflammatory bowel diseaseSaara Huoponen, Anja Eberl, Pirjo Räsänen, et al.
Journal of Clinical Microbiology|June 10, 1998
Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritisA Kokkola, H Rautelin, P Puolakkainen, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1991
Chronic gastritis: progression of inflammation and atrophy in a six-year endoscopic follow-up of a random sample of 142 Estonian urban subjectsK Villako, M Kekki, H I Maaroos, et al.
Scandinavian Journal of Gastroenterology|January 1, 1976
Immunological parameters, viral antibodies, and biochemical and histological findings in relatives of patients with chronic active hepatitis and primary biliary cirrhosisM P Salaspuro, O I Laitinen, J Lehtola, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|December 16, 2020
Well-Defined Lignin Model Films from Colloidal Lignin ParticlesMuhammad Farooq, Tao Zou, Juan José Valle-Delgado, et al.
Digestive Diseases and Sciences|February 13, 2025
Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel DiseaseJaakko Rautakorpi, Sara Kolehmainen, Eliisa Löyttyniemi, et al.
Perfusion|October 9, 2008
Whole blood hypercoagulability despite anticoagulation during mechanical cardiac assistT T Niemi, S I Kukkonen, P T Hämmäinen, et al.
Endoscopy|May 1, 1990
Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long-term follow-up examinations of a random sampleK Villako, H Maards, R Tammur, et al.
European Journal of Gastroenterology & Hepatology|July 8, 2024
Real-life experiences of switching from intravenous to subcutaneous vedolizumab maintenance therapy in patients with inflammatory bowel diseaseSara Kolehmainen, Jaakko Rautakorpi, Eliisa Löyttyniemi, et al.
Inflammatory Bowel Diseases|September 23, 2010
Endoscopic monitoring of infliximab therapy in Crohn's diseaseClas-Göran af Björkesten, Urpo Nieminen, Ulla Turunen, et al.
Pageof 46